Can Nurse-Based Management Screening Ensure Adequate Outcomes in Patients With Gestational Diabetes? A Comparison of 2 Organizational Models.

Qual Manag Health Care

Endocrinological, Metabolic and Nutrition Unit, Department of Specialized Medicine, Local Health Authority (ULSS 2), Treviso, Italy (Drs Nollino, Kiwanuka, Sambataro, Sambado, Trevisiol, and Paccagnella and Mss Marcon, Merlotto-Cazziola, and Scantamburlo); Inpatient Psychological Service, Local Health Authority (ULSS 2), Treviso, Italy (Mss Mauri and Migot); Obstetrics and Gynecology Unit, Maternal Department, Local Health Authority (ULSS 2), Treviso, Italy (Dr Busato); Local Pharmacy Service, Local Health Authority (ULSS 2), Treviso, Italy (Drs Trevisiol and Pirolo); Internal Medicine Unit, Department of Medicine, Local Health Authority (ULSS 1), Belluno, Italy (Dr Boaretto); Medical Genetics Unit, Local Health Authority (ULSS 2), Treviso, Italy (Dr Turolla); and General Management, Local Health Authority (ULSS 2), Treviso, Italy (Mr Faronato and Dr Cadamuro-Morgante).

Published: June 2019

Background: Gestational diabetes mellitus (GDM) is an impaired glucose tolerance with onset or first recognition during pregnancy. The purpose of this study is to evaluate the clinical outcomes of a blood glucose monitoring protocol implemented by nurses and dietitians in a diabetes team to the previously established protocol of direct monitoring of GDM patients by a diabetologist.

Methods: Two groups of patients were formed: The first group was based on a traditional protocol (P1: 230 patients) with patients' blood glucose constantly checked by a diabetologist. In the second structured group (P2: 220 patients) patients were referred to a diabetologist only if they required insulin therapy.

Results: The number of medical visits (P2: 1.28 ± 0.70 vs P1: 3.27 ± 1.44; P < .001) and the percentage of patients with hypoglycemia (P2: 6.8% vs P1: 15.2%; P < .006) were found to be lower in group P2 than in group P1. In both groups, a direct relationship was found between a parental history of diabetes and the risk of GDM (odds ratio [OR]: P1 = 2.2 [1.17-4.12]; P2 = 2.5 [1.26-5.12]). In group P1, it was observed that hyperweight gain in patients who were already overweight before becoming pregnant significantly increased the risk of macrosomia (OR: 3.11 [1.39-25.7]), whereas this was not detected in patients in group P2. In group P2, a correlation was found between macrosomia and insulin therapy (OR: 0.066 vs 0.34). In group P1 and group P2, a correlation was observed between insulin therapy and a family history of diabetes (OR: 2.20 vs 2.27), and a body mass index of greater than 30 kg/m in group P2 (OR: 3.0 vs 1.47).

Conclusions: The data we collected show that creating a structured protocol for GDM management reduces the number of medical visits required by patients without increasing the risk of hypoglycemia, macrosomia, or hyperweight gain during pregnancy.

Download full-text PDF

Source
http://dx.doi.org/10.1097/QMH.0000000000000202DOI Listing

Publication Analysis

Top Keywords

group group
12
patients
10
group
10
blood glucose
8
number medical
8
medical visits
8
history diabetes
8
hyperweight gain
8
group correlation
8
insulin therapy
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!